Post-authorization Safety Reporting
Post-Authorization Safety Reporting is a regulatory pharmacovigilance process that involves the systematic collection, evaluation, and submission of safety data on medicinal products following their regulatory approval to identify and mitigate previously unrecognized risks.
21
Publications
660
Citations
165
Authors
109
Institutions
Publications per year
2017–2026
9
Parents
21
1–5 of 21
165
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 165
109

Karolinska Institutet
Stockholm, Sweden
3 h-index
3 publications
85 citations

European Medicines Agency
Amsterdam, Netherlands
2 h-index
6 publications
240 citations
United States Food and Drug Administration
Silver Spring, United States
2 h-index
13 publications
229 citations
Center for Drug Evaluation and Research
Silver Spring, United States
2 h-index
13 publications
229 citations
Utrecht University
Utrecht, The Netherlands
2 h-index
4 publications
442 citations
Université Claude Bernard Lyon 1
Villeurbanne, France
1 h-index
1 publications
15 citations

Università Cattolica del Sacro Cuore
Milan, Italy
1 h-index
2 publications
26 citations

University of Pisa
Pisa, Italy
1 h-index
1 publications
13 citations
1–8 of 109
2 publications · 279 citations
2
h-index
1 publications · 17 citations
1
h-index
1 publications · 20 citations
1
h-index
1 publications · 18 citations
1
h-index
1 publications · 13 citations
1
h-index
1–5